Is RGLS or RYLD a better dividend investment in 2026?

RGLS currently yields 24.51% with a 5% 5-year dividend growth rate. RYLD yields 12.14% with 5% growth. The better choice depends on your goal: RGLS offers higher current income.

What is the dividend yield difference between RGLS and RYLD?

RGLS has a forward dividend yield of 24.51% ($2.00/share annually). RYLD yields 12.14% ($1.81/share annually). The yield gap is 12.37 percentage points.

Home › Compare › RGLS vs RYLD

RGLS vs RYLD: Dividend Comparison 2026

RGLS yields 24.51% · RYLD yields 12.14%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 RGLS wins by $51.4K in total portfolio value

INVESTMENT

TIME HORIZON10 years

RGLS

● Live price

24.51%

Share price

$8.16

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$95.9K

Annual income

$10,627.09

Full RGLS calculator →

RYLD

● Live price

12.14%

Share price

$14.95

Annual div

$1.81

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$44.5K

Annual income

$2,587.35

Full RYLD calculator →

Portfolio growth — RGLS vs RYLD

📍 RGLS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	RGLS	RYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, RGLS + RYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

RGLS pays

RYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RGLS

Annual income on $10K today (after 15% tax)

$2,083.33/yr

After 10yr DRIP, annual income (after tax)

$9,033.03/yr

RYLD

Annual income on $10K today (after 15% tax)

$1,031.60/yr

After 10yr DRIP, annual income (after tax)

$2,199.25/yr

At 15% tax rate, RGLS beats the other by $6,833.78/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RGLS + RYLD for your $10,000?

RGLS: 50%RYLD: 50%

100% RYLD50/50100% RGLS

Portfolio after 10yr

$70.2K

Annual income

$6,607.22/yr

Blended yield

9.41%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on RGLS right now

RGLS

Analyst Ratings

Buy

Hold

Consensus: Buy

Price Target

$7.00

-14.2% upside vs current

Range: $7.00 — $7.00

Altman Z

46.8

Piotroski

1/9

RYLD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RGLS buys

RYLD buys

No recent congressional trades found for RGLS or RYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricRGLSRYLD

Forward yield	24.51% ✓	12.14%
Annual dividend / share	$2.00 ✓	$1.81
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$95.9K ✓	$44.5K
Annual income after 10y	$10,627.09 ✓	$2,587.35
Total dividends collected	$60.2K ✓	$18.8K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: RGLS vs RYLD ($10,000, DRIP)

Year	RGLS Portfolio	RGLS Income/yr	RYLD Portfolio	RYLD Income/yr	Gap
1← crossover	$13,151	$2,450.98	$11,914	$1,213.65	+$1.2K → RGLS
2	$17,084	$3,012.41	$14,099	$1,351.30	+$3.0K → RGLS
3	$21,937	$3,657.30	$16,580	$1,494.55	+$5.4K → RGLS
4	$27,862	$4,389.03	$19,384	$1,642.61	+$8.5K → RGLS
5	$35,022	$5,209.71	$22,535	$1,794.70	+$12.5K → RGLS
6	$43,593	$6,120.11	$26,063	$1,950.00	+$17.5K → RGLS
7	$53,765	$7,119.64	$29,995	$2,107.69	+$23.8K → RGLS
8	$65,734	$8,206.35	$34,361	$2,266.99	+$31.4K → RGLS
9	$79,713	$9,376.98	$39,194	$2,427.12	+$40.5K → RGLS
10	$95,920	$10,627.09	$44,525	$2,587.35	+$51.4K → RGLS

RGLS vs RYLD: Complete Analysis 2026

RGLS — Stock

Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-threatening kidney disease; and RGLS8429, an anti-miR targeting miR-17, which is in Phase 1b clinical study for the treatment of autosomal dominant polycystic kidney disease. The company is also developing a pipeline of preclinical drug products for target organ-selective delivery strategies. Regulus Therapeutics Inc. was incorporated in 2007 and is headquartered in San Diego, California.

Full RGLS Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →

📬

Get this RGLS vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RGLS vs SCHD RGLS vs JEPI RGLS vs O RGLS vs KO RGLS vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.